Unibest
← Back to patent-cliff list

CAS 3886-70-2

(R)-1-(naphthalen-1-yl)ethan-1-amine

Codes: EVOCA-003, CINA-006

Application context (from source-drug indications)

Secondary hyperparathyroidismEvocalcetParathyroid carcinomaEvocalcetPrimary hyperparathyroidismEvocalcetHyperparathyroidismEvocalcetHypercalcaemiaCinacalcet HydrochlorideSecondary hyperparathyroidismCinacalcet HydrochlorideHyperparathyroidismCinacalcet HydrochloridePrimary hyperparathyroidismCinacalcet HydrochlorideChronic renal impairmentCinacalcet HydrochlorideCardiogenic oedemaCinacalcet Hydrochloride

Source drugs (routes using this intermediate)

DrugTierExpiry
EvocalcetTier C — Watch / trade-
Cinacalcet HydrochlorideTier B — Position early-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Cinacalcet HydrochlorideOptimised routesteps: 4total yield: 25.8 g

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.